Show simple item record

dc.contributor.authorTorabi, Raheleh et al.
dc.date.accessioned2021-05-25T13:49:13Z
dc.date.available2021-05-25T13:49:13Z
dc.date.issued2020-10
dc.identifier.urihttps://doi.org/10.1016/j.mcp.2020.101636en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12663/2615
dc.description.abstractAbstract The recently known coronavirus, SARS-CoV-2, has turn into the greatest global health challenge, affecting a large number of societies. The lack of specific treatment and gold-standard diagnostic system has made the situation more complicated. Efforts have led to production of several diagnostic kits that are associated with limitations such as inadequate sensitivity and accuracy. Aptamers as multipotent biological probes could be promising candidates to design sensitive and specific biosensors. Although few studies have introduced specific aptamer types of coronavirus, they may help us select the best approach to obtain specific aptamers for this virus. On the other hand, some of already-introduced aptamers have shown the inhibitory effects on coronavirus that could be applied as therapeutics. The present study has provided a systematic overview on use of aptamer-based biosensors and drugs to diagnose and treat coronavirus.en_US
dc.languageEnglishen_US
dc.subjectTherapeuticsen_US
dc.subjectCOVID-19en_US
dc.subjectCoronavirus Infectionsen_US
dc.subjectCoronavirusen_US
dc.subjectSARS-CoV-2en_US
dc.subjectSystematic Reviewen_US
dc.titleAptamers, the bivalent agents as probes and therapies for coronavirus infections: A systematic reviewen_US
eihealth.countryOthersen_US
eihealth.categoryVirus: natural history, transmission and diagnosticsen_US
eihealth.categoryCandidate therapeutics RDen_US
eihealth.typePublished Articleen_US
eihealth.maincategorySlow Spread / Reducir la Dispersiónen_US
dc.relation.ispartofjournalMol Cell Probesen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record